SCHEMBL16067757

SCHEMBL16067757

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3ccc4oc5c6ccccc6c6ccccc6c5c4c3)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.38
▸ WEE1 P30291 1/20 0.36
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALPI P09923 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ CASP6 P55212 1/20 0.35
▸ MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16067661 0.96 PLA2G2A (0.40) ALOX5WEE1PLA2G2APLA2G4AL3MBTL1
SCHEMBL17931914 0.92 CDC14B (0.36) ALOX5WEE1PLA2G2APLA2G4AL3MBTL1
SCHEMBL16067589 0.90 PLA2G2A (0.40) ALOX5WEE1PLA2G2APLA2G4AL3MBTL1
SCHEMBL20053316 0.90 ALOX5 (0.37) ALOX5WEE1PLA2G2APLA2G4AL3MBTL1
SCHEMBL24662831 0.90 ALOX5 (0.42) ALOX5WEE1PLA2G2APLA2G4AL3MBTL1
SCHEMBL17122587 0.89 ALOX5 (0.35) ALOX5L3MBTL1MEN1MAPTKMT2A
SCHEMBL16067790 0.89 PLA2G2A (0.41) ALOX5PLA2G2APLA2G4AL3MBTL1MEN1
SCHEMBL16067987 0.89 KMT2A (0.39) ALOX5PLA2G2APLA2G4AL3MBTL1MEN1
SCHEMBL24663070 0.87 ALOX5 (0.39) ALOX5WEE1PLA2G2APLA2G4AL3MBTL1
SCHEMBL16067986 0.86 ALOX5 (0.50) ALOX5PLA2G2APLA2G4AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3388496-B1 ORGANIC LIGHT-EMITTING ELEMENT COMPRISING DIBENZOFURAN-ANTHRACENE DERIVATIVE IN LIGHT EMITTING LAYER AND DIPHENYLMETHYL DERIVATIVE IN ELECTRON INJECTION LAYER LG CHEMICAL LTD (KR) 2021-02-24 — — EP disclosed
US-20200136053-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2020-04-30 — — US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 — — US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 — — US disclosed
US-20180198077-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2018-07-12 — — US disclosed
US-20180198077-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2018-07-12 — — US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 — — US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 — — US disclosed
US-9947879-B2 Anthracene derivative and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-04-17 — — US disclosed
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-11-12 — — US disclosed
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-11-12 — — US disclosed
EP-2924029-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME Idemitsu Kosan Co., Ltd (JP) 2015-09-30 — — EP disclosed
WO-2014141725-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME 出光興産株式会社 (JP) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885WEE1 3100/4885PLA2G2A 2960/4885
US-20180198077-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME ANXA1, ANXA11, L1CAM ALOX5 1507/4885WEE1 1590/4885PLA2G2A 1281/4885
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME ANXA1, ANXA11, L1CAM ALOX5 1507/4885WEE1 1590/4885PLA2G2A 1281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback